These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 25376956)
1. Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies. Notarnicola A; Lapadula G; Natuzzi D; Iannone F Reumatismo; 2014 Nov; 66(3):215-23. PubMed ID: 25376956 [TBL] [Abstract][Full Text] [Related]
2. Correlation between serum levels of IL-15 and IL-17 in patients with idiopathic inflammatory myopathies. Notarnicola A; Lapadula G; Natuzzi D; Lundberg IE; Iannone F Scand J Rheumatol; 2015 May; 44(3):224-8. PubMed ID: 25379698 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-35 in idiopathic inflammatory myopathies. Mann H; Kryštůfková O; Zámečník J; Háček J; Hulejová H; Filková M; Vencovský J; Šenolt L Cytokine; 2021 Jan; 137():155350. PubMed ID: 33128920 [TBL] [Abstract][Full Text] [Related]
4. The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis. Yin L; Ge Y; Yang H; Peng Q; Lu X; Zhang Y; Wang G Clin Rheumatol; 2016 Nov; 35(11):2715-2721. PubMed ID: 27502600 [TBL] [Abstract][Full Text] [Related]
5. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Lundberg I; Ulfgren AK; Nyberg P; Andersson U; Klareskog L Arthritis Rheum; 1997 May; 40(5):865-74. PubMed ID: 9153548 [TBL] [Abstract][Full Text] [Related]
6. Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis. Silva MG; Oba-Shinjo SM; Marie SKN; Shinjo SK Clin Exp Rheumatol; 2019; 37(4):656-662. PubMed ID: 30620283 [TBL] [Abstract][Full Text] [Related]
7. The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies. Lundberg IE Curr Rheumatol Rep; 2000 Jun; 2(3):216-24. PubMed ID: 11123062 [TBL] [Abstract][Full Text] [Related]
8. Resistin in idiopathic inflammatory myopathies. Filková M; Hulejová H; Kuncová K; Pleštilová L; Cerezo LA; Mann H; Klein M; Zámečník J; Gay S; Vencovský J; Senolt L Arthritis Res Ther; 2012 May; 14(3):R111. PubMed ID: 22577940 [TBL] [Abstract][Full Text] [Related]
9. Serum BAFF in Indian patients with IIM: a retrospective study reveals novel clinico-phenotypic associations in children and adults. Gupta L; Chaurasia S; Srivastava P; Dwivedi S; Lawrence A; Misra R Clin Rheumatol; 2018 May; 37(5):1265-1271. PubMed ID: 29516280 [TBL] [Abstract][Full Text] [Related]
10. [Expression of interferon and its correlation with clinical features in idiopathic inflammatory myopathies]. Zu N; Wang GC Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1157-60. PubMed ID: 21756766 [TBL] [Abstract][Full Text] [Related]
11. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies. Grundtman C; Salomonsson S; Dorph C; Bruton J; Andersson U; Lundberg IE Arthritis Rheum; 2007 Feb; 56(2):674-87. PubMed ID: 17265504 [TBL] [Abstract][Full Text] [Related]
12. [Association between cytokines and trichloroethylene-induced hypersensitivity dermatitis]. Zang D; Yi J; Dong HY; Zhou W; Huang XQ; Duan HW; Bin P; Niu Y; Zheng YX; Dai YF Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Sep; 46(9):836-9. PubMed ID: 23157890 [TBL] [Abstract][Full Text] [Related]
13. Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis. Lundberg I; Kratz AK; Alexanderson H; Patarroyo M Arthritis Rheum; 2000 Feb; 43(2):336-48. PubMed ID: 10693873 [TBL] [Abstract][Full Text] [Related]
14. Increased levels of HSPA5 in the serum of patients with inflammatory myopathies--preliminary findings. Xiao F; Tan JZ; Xu XY; Wang XF Clin Rheumatol; 2015 Apr; 34(4):715-20. PubMed ID: 25750184 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-18 overexpression as a hallmark of the activity of autoimmune inflammatory myopathies. Tucci M; Quatraro C; Dammacco F; Silvestris F Clin Exp Immunol; 2006 Oct; 146(1):21-31. PubMed ID: 16968394 [TBL] [Abstract][Full Text] [Related]
16. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies. Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284 [TBL] [Abstract][Full Text] [Related]
17. Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor α expression in muscle tissue of patients with polymyositis or dermatomyositis. Zong M; Loell I; Lindroos E; Nader GA; Alexanderson H; Hallengren CS; Borg K; Arnardottir S; McInnes IB; Lundberg IE Ann Rheum Dis; 2012 Jun; 71(6):1055-63. PubMed ID: 22267334 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) axis in idiopathic inflammatory myopathies and its association with laboratory and clinical parameters: a pilot study. Opinc A; Sarnik J; Brzezińska O; Makowski M; Lewandowska-Polak A; Makowska J Rheumatol Int; 2020 Jul; 40(7):1133-1141. PubMed ID: 32222805 [TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha in inflammatory myopathies: pathophysiology and therapeutic implications. Efthimiou P Semin Arthritis Rheum; 2006 Dec; 36(3):168-72. PubMed ID: 16970978 [TBL] [Abstract][Full Text] [Related]
20. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies. Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]